The family of six complementary patents covers methods of genetic analysis used to detect markers for multifactorial traits.
According to the company, these methods range from identification of tightly linked haplotype blocks and multi-loci markers to optimal matching of patient cases and controls, as well as methods for managing the massive data sets that accompany these analyses.
Bryan Walser, CEO of Perlegen, said: “The ability to determine which genetic markers are present in an individual across several areas of the genome – and combine them in order to help quantify risk of developing or showing a specific multifactorial trait – will be central to the field of genetic diagnostics going forward.”